INS and type 1 diabetes mellitus: Consistent with this, administration of chemically fixed splenic antigen-presenting cells coupled with intact insulin or the dominant insulin epitopes, but not epitopes of other autoantigens, protected 4–6-week-old NOD mice from development of T1D, which also indicated insulin is the key initiating autoantigen (34).